R. Tarrell

发表

Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers.

V. Pankratz, F. Couch, B. Ponder, 2010, Human molecular genetics.

Institution-wide QT alert system identifies patients with a high risk of mortality.

Michael J Ackerman, Pedro J Caraballo, P. Caraballo, 2013, Mayo Clinic proceedings.

A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general population

Christiana Kartsonaki, Mads Thomassen, Julian Peto, 2010, Nature Genetics.

Increased risk of herpes zoster in children with asthma: a population-based case-control study.

B. Yawn, Y. Juhn, R. Tarrell, 2013, The Journal of pediatrics.

Perioperative blood transfusion and radical cystectomy: does timing of transfusion affect bladder cancer mortality?

R. Thompson, S. Boorjian, I. Frank, 2014, European urology.

Does partial cystectomy compromise oncologic outcomes for patients with bladder cancer compared to radical cystectomy? A matched case-control analysis.

J. Cheville, S. Boorjian, I. Frank, 2012, The Journal of urology.

Prevalence and Outcome of High-Risk QT Prolongation Recorded in the Emergency Department from an Institution-Wide QT Alert System.

P. Caraballo, M. Ackerman, R. Tarrell, 2018, The Journal of emergency medicine.

Frequency and cause of transient QT prolongation after surgery.

P. Caraballo, M. Ackerman, R. Tarrell, 2015, The American journal of cardiology.

Comparative impact of continent and incontinent urinary diversion on long‐term renal function after radical cystectomy in patients with preoperative chronic kidney disease 2 and chronic kidney disease 3a

R. Thompson, S. Boorjian, I. Frank, 2015, International journal of urology : official journal of the Japanese Urological Association.

396 CANCER-SPECIFIC MORTALITY FOLLOWING RADICAL CYSTECTOMY FOR BLADDER CANCER WITH LYMPH NODE INVOLVEMENT: IMPACT OF DISEASE FEATURES AND ADJUVANT CHEMOTHERAPY

J. Cheville, S. Boorjian, I. Frank, 2013 .

Clinical Decision Support to Detect High Risk Patients with QTc Prolongation

Pedro J. Caraballo, Michael J. Ackerman, György J. Simon, 2016, AMIA.

Providers’ Response to Clinical Decision Support for QT Prolonging Drugs

Pedro J. Caraballo, Michael J. Ackerman, György J. Simon, 2017, Journal of Medical Systems.

Long‐term results of radical cystectomy and role of adjuvant chemotherapy for small cell carcinoma of the bladder

J. Cheville, R. Thompson, S. Boorjian, 2015, International journal of urology : official journal of the Japanese Urological Association.

Outcome of patients with micropapillary urothelial carcinoma following radical cystectomy: ERBB2 (HER2) amplification identifies patients with poor outcome

J. Cheville, R. Thompson, S. Boorjian, 2014, Modern Pathology.

Prognostic significance of measured depth of invasion of urothelial carcinoma of the bladder compared to the 2010 American Joint Committee on Cancer pT2 and pT3 classifications.

J. Cheville, R. Thompson, S. Boorjian, 2012, The Journal of urology.

Outcomes following radical cystectomy for micropapillary bladder cancer versus pure urothelial carcinoma: a matched cohort analysis

J. Cheville, S. Boorjian, I. Frank, 2012, World Journal of Urology.

A multivariable model using advanced cytologic methods for the evaluation of indeterminate pancreatobiliary strictures.

G. Gores, A. Clayton, L. Roberts, 2009, Gastroenterology.

Sarcopenia and Response to Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer.

Paras H Shah, J. Cheville, S. Boorjian, 2019, Clinical genitourinary cancer.

Association of intraoperative hypothermia with oncologic outcomes following radical cystectomy.

Paras H Shah, S. Boorjian, I. Frank, 2020, Urologic oncology.

Radical cystectomy for recurrent urothelial carcinoma after prior partial cystectomy: perioperative and oncologic outcomes

R. Thompson, S. Boorjian, I. Frank, 2017, World Journal of Urology.

Cystectomy for refractory hemorrhagic cystitis: contemporary etiology, presentation and outcomes.

S. Boorjian, R. Tarrell, B. Linder, 2015, The Journal of urology.

Evaluation of the Malfunctions of a Clinical Decision Support System Dependent on Electrocardiograms and Measurement of the QT Interval

Christopher A. Aakre, P. Caraballo, M. Ackerman, 2017 .

Perioperative and Oncologic Outcomes Associated with Simultaneous Radical Cystectomy and Nephroureterectomy.

Paras H Shah, S. Boorjian, I. Frank, 2022, Urology.

The Association of Aspirin Use with Survival Following Radical Cystectomy

Paras H Shah, J. Cheville, S. Boorjian, 2018, The Journal of urology.

Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers

Peter Devilee, Alfons Meindl, Lesley McGuffog, 2010, Breast Cancer Research.

The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy.

J. Cheville, R. Thompson, S. Boorjian, 2013, European urology.

Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy.

R. Thompson, S. Boorjian, I. Frank, 2014, European urology.

Sarcopenia in patients with bladder cancer undergoing radical cystectomy: Impact on cancer‐specific and all‐cause mortality

J. Cheville, S. Boorjian, S. Psutka, 2014, Cancer.

Comprehensive characterization of perioperative reoperation following radical cystectomy.

Paras H Shah, J. Cheville, R. Thompson, 2019, Urologic oncology.

Persistent, long-term risk for ureteroenteric anastomotic stricture formation: the case for long term follow-up.

S. Boorjian, R. Tarrell, B. Viers, 2020, Translational andrology and urology.

Prognostic significance of lymphatic, vascular and perineural invasion for bladder cancer patients treated by radical cystectomy.

J. Cheville, R. Thompson, S. Boorjian, 2017, Pathology.

Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis.

Stephen A Boorjian, J. Cheville, R. Thompson, 2017, European urology.

Outcomes following radical cystectomy for nested variant of urothelial carcinoma: a matched cohort analysis.

J. Cheville, R. Thompson, S. Boorjian, 2013, The Journal of urology.

The association of ABO blood type with disease recurrence and mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy.

J. Cheville, S. Boorjian, I. Frank, 2016, Urologic oncology.

The impact of histological reclassification during pathology re-review--evidence of a Will Rogers effect in bladder cancer?

J. Cheville, S. Boorjian, I. Frank, 2013, The Journal of urology.

Outcomes Following Radical Cystectomy for Plasmacytoid Urothelial Carcinoma: Defining the Need for Improved Local Cancer Control.

J. Cheville, S. Boorjian, I. Frank, 2015, Urology.

Malignant ureteroenteric anastomotic stricture following radical cystectomy with urinary diversion: Patterns, risk factors, and outcomes.

William P. Parker, S. Boorjian, I. Frank, 2016, Urologic oncology.

Intravesical gemcitabine in combination with mitomycin C as salvage treatment in recurrent non‐muscle‐invasive bladder cancer

I. Frank, R. Karnes, R. Tarrell, 2016, BJU international.

No evidence that GATA3 rs570613 SNP modifies breast cancer risk

K. Czene, P. Hall, V. Pankratz, 2009, Breast Cancer Research and Treatment.

Evidence for SMAD 3 as a modifier of breast cancer risk in BRCA 2 mutation carriers

V. Pankratz, F. Couch, T. Rebbeck, 2010 .

Long-term renal function outcomes after radical cystectomy.

R. Thompson, S. Boorjian, I. Frank, 2014, The Journal of urology.

Non-O blood type is associated with an increased risk of venous thromboembolism after radical cystectomy.

S. Boorjian, I. Frank, R. Tarrell, 2013, Urology.

Mortality after radical cystectomy: impact of obesity versus adiposity after adjusting for skeletal muscle wasting.

S. Boorjian, S. Psutka, I. Frank, 2015, The Journal of urology.

Late recurrence after radical cystectomy: patterns, risk factors and outcomes.

J. Cheville, S. Boorjian, I. Frank, 2014, Journal of Urology.

Long-term outcomes of incidental prostate cancer at radical cystectomy.

J. Cheville, R. Thompson, S. Boorjian, 2020, Urologic oncology.

Urothelial carcinoma involving the prostate: the association of revised tumour stage and coexistent bladder cancer with survival after radical cystectomy

J. Cheville, S. Boorjian, I. Frank, 2014, BJU international.

Intraoperative Blood Transfusion Is Associated With Increased Risk of Venous Thromboembolism After Radical Cystectomy

Paras H Shah, R. Thompson, S. Boorjian, 2022, The Journal of urology.

The association of salvage intravesical therapy following BCG with pathologic outcomes and survival after radical cystectomy for patients with high-grade non-muscle invasive bladder cancer: A multi-institution analysis.

J. Cheville, S. Boorjian, I. Frank, 2021, Urologic oncology.

Gender-specific survival following radical cystectomy for pT4 bladder cancer

J. Cheville, R. Thompson, S. Boorjian, 2014, World journal of urology.

A Contemporary Analysis of Urethral Recurrence following Radical Cystectomy.

Paras H Shah, R. Thompson, S. Boorjian, 2021, The Journal of urology.

Impact of left ventricular hypertrophy on QT prolongation and associated mortality.

P. Caraballo, M. Ackerman, R. Tarrell, 2014, Heart rhythm.

Letters to the Editor/Errata Re: Does Partial Cystectomy Compromise Oncologic Outcomes for Patients with Bladder Cancer Compared to Radical Cystectomy? A Matched Case-Control Analysis

J. Cheville, S. Boorjian, I. Frank, 2013 .

Phenotype of Children with QT Prolongation Identified Using an Institution-Wide QT Alert System

P. Caraballo, M. Ackerman, R. Tarrell, 2015, Pediatric Cardiology.

Asthma and Risk of Herpes Zoster in Children: A Population-Based Case-Control Study

B. Yawn, Y. Juhn, R. Tarrell, 2012 .

Outcomes of patients with high-risk non-muscle invasive bladder cancer (NMIBC) who undergo radical cystectomy after BCG and subsequent salvage intravesical therapy.

J. Cheville, S. Boorjian, I. Frank, 2020 .

Impact of clinical decision support preventing the use of QT-prolonging medications for patients at risk for torsade de pointes

Pedro J. Caraballo, Michael J. Ackerman, J. Martijn Bos, 2015, J. Am. Medical Informatics Assoc..

Cutaneous Ureterostomy Following Radical Cystectomy for Bladder Cancer: A Contemporary Series

Paras H Shah, S. Boorjian, I. Frank, 2023, Urology.

Urothelial carcinoma involving the prostate: the association of revised tumour stage and coexistent bladder cancer with survival after radical cystectomy

J. Cheville, S. Boorjian, I. Frank, 2014, BJU international.

Survival for patients with residual tumor at radical cystectomy following chemotherapy: A matched analysis to cystectomy-only patients.

J. Cheville, S. Boorjian, I. Frank, 2017 .

A multivariable model using advanced cytologic methods for the evaluation of indeterminate pancreatobiliary strictures.

G. Gores, A. Clayton, L. Roberts, 2009, Gastroenterology.

Intravesical gemcitabine in combination with mitomycin C as salvage treatment in recurrent non‐muscle‐invasive bladder cancer

I. Frank, R. Karnes, R. Tarrell, 2016, BJU international.

Prognostic significance of measured depth of invasion of urothelial carcinoma of the bladder compared to the 2010 American Joint Committee on Cancer pT2 and pT3 classifications.

J. Cheville, S. Boorjian, I. Frank, 2012, Journal of Urology.

S. Boorjian, I. Frank, R. Tarrell, 2014, European urology.